• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Friday RX numbers out for Viekira Pak

Quote

Anonymous

Guest
@H3NPHLO: #Viekira: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 870 NRx@ 536. $ABBV
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 413. NRx@ 216. $ABBV

@H3NPHLO: #Harvoni: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 10,080 NRx@ 4,535. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 9,795. NRx@ 3,799. $GILD

@H3NPHLO: #Sovaldi: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 2,060 NRx@ 868. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 1,916. NRx@ 700. $GILD

Follow on Twitter.
 




Anonymous said:
@H3NPHLO: #Viekira: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 870 NRx@ 536. $ABBV
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 413. NRx@ 216. $ABBV

@H3NPHLO: #Harvoni: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 10,080 NRx@ 4,535. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 9,795. NRx@ 3,799. $GILD

@H3NPHLO: #Sovaldi: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 2,060 NRx@ 868. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 1,916. NRx@ 700. $GILD

Follow on Twitter.
Click to expand...

Another pitiful week of Rx performance!! Ricky earn your salary and DO something/anything!! Abby Retirees United
 




































@H3NPHLO: #Viekira: Prescr. figures for wk ending 4/10 (Symphony/BBG) : TRx@ 789 NRx@ 437. $ABBV
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 344 NRx@ 159. $ABBV

@H3NPHLO: #Harvoni: Prescr. figures for wk ending 4/10 (Symphony/BBG) : TRx@ 9,730 NRx@ 4,102. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 10,071 NRx@ 3,841. $GILD

@H3NPHLO: #Sovaldi: Prescr. figures for wk ending 4/10 (Symphony/BBG) : TRx@ 1,997 NRx@ 731.
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 1,837 NRx@ 591. $GILD

geno 1 MS 5% VK 95% Harv
 




Anonymous said:
@H3NPHLO: #Viekira: Prescr. figures for wk ending 4/10 (Symphony/BBG) : TRx@ 789 NRx@ 437. $ABBV
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 344 NRx@ 159. $ABBV

@H3NPHLO: #Harvoni: Prescr. figures for wk ending 4/10 (Symphony/BBG) : TRx@ 9,730 NRx@ 4,102. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 10,071 NRx@ 3,841. $GILD

@H3NPHLO: #Sovaldi: Prescr. figures for wk ending 4/10 (Symphony/BBG) : TRx@ 1,997 NRx@ 731.
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 1,837 NRx@ 591. $GILD

geno 1 MS 5% VK 95% Harv
Click to expand...

We went down from last week! WTH is our sale force doing? NOTHING!!!!!!!
 








Big deal! Harvoni numbers went down too. Our product SUCKS. Nobody wants it unless forced by ESI. Even then, they get 1 rx and don't refill that piece of crap.

Now, let's blame the real cause of this situation. Every single person in Abbott Park that touched VPak should be fired. Dump the drug amd don't blame the reps. We would have 0 rx's if we didnt have such stellar reps working hard. This dog is hard to spell, sell, and smell! Piece of crap!!!
 




Anonymous said:
Big deal! Harvoni numbers went down too. Our product SUCKS. Nobody wants it unless forced by ESI. Even then, they get 1 rx and don't refill that piece of crap.

Now, let's blame the real cause of this situation. Every single person in Abbott Park that touched VPak should be fired. Dump the drug amd don't blame the reps. We would have 0 rx's if we didnt have such stellar reps working hard. This dog is hard to spell, sell, and smell! Piece of crap!!!
Click to expand...

I agree 110%. The company cherry picked the best reps and MSLs in the industry. I would bet that half of the VPak scripts that have been written wouldn't have had the reps not been in theface of the providers.

This dog is not only hard to sell but even tougher to give away. How many providers are refusing the vouchers and making up bogus excuses. I heard one the other day. A provider said he didn't want the voucher because he didn't want the word getting out on the street that he gives away free medicine.

And the voucher program is a disaster. The providers are using it mainly for those who they couldn't get Harvoni approved. Very few GT 1As. And these patients are on concomitant meds that we didn't study and are not listed in hep-druginteractions.org
 




Anonymous said:
I agree 110%. The company cherry picked the best reps and MSLs in the industry. I would bet that half of the VPak scripts that have been written wouldn't have had the reps not been in theface of the providers.

This dog is not only hard to sell but even tougher to give away. How many providers are refusing the vouchers and making up bogus excuses. I heard one the other day. A provider said he didn't want the voucher because he didn't want the word getting out on the street that he gives away free medicine.

And the voucher program is a disaster. The providers are using it mainly for those who they couldn't get Harvoni approved. Very few GT 1As. And these patients are on concomitant meds that we didn't study and are not listed in hep-druginteractions.org
Click to expand...

More excuses
 












Anonymous said:
@H3NPHLO: #Viekira: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 870 NRx@ 536. $ABBV
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 413. NRx@ 216. $ABBV

@H3NPHLO: #Harvoni: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 10,080 NRx@ 4,535. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 9,795. NRx@ 3,799. $GILD

@H3NPHLO: #Sovaldi: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 2,060 NRx@ 868. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 1,916. NRx@ 700. $GILD

Follow on Twitter.
Click to expand...

What stock do you put in Friday's numbers Vs. Monday's numbers?
 








Top Bottom
Back
Quote